Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Listing Application

17 Oct 2017 14:49

RNS Number : 8516T
Maven Income & Growth VCT 4 PLC
17 October 2017
 

Maven Income and Growth VCT 4 PLC (the Company) - Statement re Listing Application

 

 

The Announcement below was originally released on 26 March 2013, however admission did not take place. The shares will now formally be admitted on 19 October 2017. Please note, as a result of subsequent share issues and buy-backs, the Company confirms that its issued share capital as at 17 October 2017 comprises 32,704,925 Ordinary Shares, with each share carrying one voting right.

 

 

Maven Income and Growth VCT 4 PLC

 

Results of Shareholder Meetings and Share Capital Consolidation

 

26 March 2013

 

This announcement is made by Maven Income and Growth VCT 4 PLC ("the Company") in connection with (i) the proposed consolidation of its share capital ("Share Consolidation") and (ii) the proposed merger of the Company with Ortus VCT PLC ("Ortus"), which will be completed pursuant to a scheme of reconstruction under Section 110 of the Insolvency Act 1986 whereby Ortus will transfer all of its assets and liabilities to the Company in consideration of shares being issued by the Company ("the Scheme"), details of which were contained in the Company's circular to shareholders ("Circular") and prospectus ("Prospectus") both dated 1 March 2013.

 

Results of the General Meeting and Class Meetings

 

The Board is pleased to announce that at the general meeting and class meetings of the Company held on 26 March 2013, the resolutions proposed in connection with the Share Consolidation and the Scheme and other matters, as set out in the Circular, were duly passed on a show of hands.

 

Details of the resolutions passed at the general meeting are as follows:

 

· Resolution 1 to: (i) authorise the directors to allot shares pursuant to the share consolidation; (ii) redesignate each S ordinary share of 10p each ("S Shares") as an ordinary share of 10p each ("Ordinary Shares") and (iii) amend the articles of association of the Company to remove any reference to S Shares as a separate class of shares - 97.59% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 2 to: (i) approve the acquisition of all of the assets and liabilities of Ortus VCT PLC; (ii) amend the articles of association of the Company to provide for the rights attaching to, and the conversion of, C ordinary shares; (iii) authorise the directors to allot shares pursuant to the Scheme and (iv) authorise the buyback of deferred shares - 96.49% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 3 to approve a change to the investment policy as detailed in Part V of the Circular - 98.91% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 4 to: (i) authorise the directors to allot shares; (ii) disapply pre-emption rights and (iii) authorise the Company to make market purchases of shares - 98.74% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 5 to: (i) authorise the cancellation of the amount standing to the credit of the share premium account as at the date an order is made the court and (ii) authorise the cancellation of the amount standing to the credit of the capital redemption reserve as at the date an order is made the court - 100% of proxy votes received being in favour (or at the chairman's discretion).

The resolutions passed at the Ordinary Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the Ordinary Shares resulting therefrom - 97.06% and 97.06% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

The resolutions passed at the S Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the S Shares resulting therefrom - 81.80% and 81.80% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

A copy of the resolutions passed at the meetings will shortly be available for inspection on both the Company's website (www.mavencp.com) as well as at the National Storage Mechanism (www.morningstar.co.uk/uk/NSM).

 

 

Share Consolidation

 

Pursuant to the Share Consolidation, 804,028 new S Shares have been issued today to the holders of S Shares on the Company's register on 25 March 2013 (this being the record date for the Share Consolidation). Application has been made to the UK Listing Authority for such shares to be admitted to the premium segment of the Official List, which is expected to take place on 27 March 2013.

 

Pursuant to Resolution 1 which was passed at the general meeting, immediately following the admission of such new S Shares to the Official List, all the S Shares then in issue in the capital of the Company will be redesignated as Ordinary Shares on a ratio of one to one. As a result, following completion of the Share Consolidation, holders of S Shares will hold 1.1528 Ordinary Shares for every S Share held on the record date for the Share Consolidation.

 

Applications will be made to the UK Listing Authority and London Stock Exchange in connection with the listing and admission of the new Ordinary Shares resulting from the Share Consolidation (and cancellation of the S Shares listing) which is expected to take effect on 28 March 2013. CREST accounts of shareholders who hold their Shares in CREST are expected to be updated and re-credited by 28 March 2013, with replacement share certificates dispatched to those who hold their share in certificated form expected to take place on 10 April 2013.

 

Following completion of the Share Consolidation, 15,225,880 Shares will be in issue. Therefore, the total number of voting rights in the Company will be 15,225,880, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

For further enquiries please contact:

 

Maven Capital Partners UK LLP

0141 306 7400

enquries@mavencp.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRXDLFFDBFZFBE
Date   Source Headline
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
15th Jun 20174:00 pmRNSDividend Declaration
12th Jun 20174:24 pmRNSTransaction in Own Shares
17th May 20172:33 pmRNSNet Asset Value and Final Dividend
17th May 20172:25 pmRNSResult of AGM
7th Apr 20173:45 pmRNSAnnual Financial Report
2nd Mar 20173:11 pmRNSTransaction in Own Shares
28th Feb 20172:40 pmRNSNet Asset Value and Final Dividend
20th Dec 20164:51 pmRNSTransaction in Own Shares
10th Nov 201611:05 amRNSNet Asset Value(s)
23rd Sep 20165:10 pmRNSTransaction in Own Shares
20th Sep 20164:56 pmRNSTransaction in Own Shares
26th Aug 20164:07 pmRNSHalf-year Report
17th Aug 20162:12 pmRNSNet Asset Value(s)
24th May 20163:06 pmRNSTransaction in Own Shares
27th Apr 20161:50 pmRNSNet Asset Value(s) - Replacement
27th Apr 201612:58 pmRNSResult of AGM
27th Apr 201612:55 pmRNSNet Asset Value(s)
30th Mar 20165:29 pmRNSAnnual Financial Report
22nd Mar 20162:44 pmRNSTransaction in Own Shares
10th Mar 20164:55 pmRNSTransaction in Own Shares
8th Mar 20164:37 pmRNSTransaction in Own Shares
7th Mar 20164:33 pmRNSTransaction in Own Shares
2nd Mar 20164:09 pmRNSNet Asset Value and Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Nov 20154:36 pmRNSTransaction in Own Shares
17th Nov 201512:59 pmRNSTransaction in Own Shares
16th Nov 20152:17 pmRNSTransaction in Own Shares
12th Nov 201510:34 amRNSNet Asset Value(s)
4th Sep 20153:20 pmRNSTransaction in Own Shares
28th Aug 201512:20 pmRNSHalf Yearly Report
24th Aug 20153:39 pmRNSStatement re Dividend Investment Scheme
20th Aug 20154:50 pmRNSTransaction in Own Shares
20th Aug 201511:47 amRNSStatement re Net Asset Value and Dividend
23rd Jun 20154:51 pmRNSTransaction in Own Shares
12th Jun 201510:02 amRNSIssue of Equity
5th Jun 20153:18 pmRNSNet Asset Value(s)
27th May 20159:34 amRNSTransaction in Own Shares
15th May 20152:17 pmRNSTransaction in Own Shares
14th May 201512:38 pmRNSTransaction in Own Shares
13th May 20153:21 pmRNSTransaction in Own Shares
12th May 20154:39 pmRNSNet Asset Value(s)
29th Apr 20152:13 pmRNSDirectorate Change
29th Apr 20152:13 pmRNSResult of AGM
13th Apr 20153:12 pmRNSIssue of Equity
30th Mar 20152:26 pmRNSTransaction in Own Shares
26th Mar 201512:52 pmRNSTransaction in Own Shares
25th Mar 20152:38 pmRNSTransaction in Own Shares
24th Mar 20154:37 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.